Lawrence F. Eichenfield
Impact in
- Dermatology top 0.01%
- Dermatology and Skin Diseases
- Acne and Rosacea Treatments and Effects
- Contact Dermatitis and Allergies
- Immunology and Allergy top 0.05%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Papers in
- Dermatology 341
- Dermatology and Skin Diseases 263
- Acne and Rosacea Treatments and Effects 75
- Contact Dermatitis and Allergies 25
-
- Allergic Rhinitis and Sensitization 86
- Food Allergy and Anaphylaxis Research 80
- Co-authors
- Amy S. Paller (91 shared papers)Sheila Fallon Friedlander (34 shared papers)Eric L. Simpson (56 shared papers)Jon M. Hanifin (10 shared papers)Mark Boguniewicz (26 shared papers)Magdalene Dohil (8 shared papers)Andrew C. Krakowski (11 shared papers)Adelaide A. Hebert (49 shared papers)
- Journals
- Journal of the American Academy of Dermatology (75 papers)Pediatric Dermatology (54 papers)Seminars in Cutaneous Medicine and Surgery (38 papers)British Journal of Dermatology (26 papers)PEDIATRICS (20 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Lawrence F. Eichenfield
433 papers receiving 12.5k citations
Lawrence F. Eichenfield's Hit Papers
Peers
Comparison fields: 5 of 157
- Dermatology 9.0k
- Immunology and Allergy 3.6k
- Rheumatology 1.1k
- Immunology 1.4k
- Speech and Hearing 342
Countries citing papers authored by Lawrence F. Eichenfield
This map shows the geographic impact of Lawrence F. Eichenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence F. Eichenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence F. Eichenfield more than expected).
Fields of papers citing papers by Lawrence F. Eichenfield
This network shows the impact of papers produced by Lawrence F. Eichenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence F. Eichenfield. The network helps show where Lawrence F. Eichenfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence F. Eichenfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 462 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults Hit paper breakdown → | 2016 | 437 |
| 2 | 2008 | 297 | |
| 3 | 2002 | 280 | |
| 4 | Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE) Hit paper breakdown → | 2018 | 256 |
| 5 | Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis Hit paper breakdown → | 2020 | 255 |
| 6 | 2001 | 253 | |
| 7 | Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies Hit paper breakdown → | 2021 | 225 |
| 8 | Management of Acne Vulgaris Hit paper breakdown → | 2021 | 223 |
| 9 | 2003 | 212 | |
| 10 | 2002 | 205 | |
| 11 | Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis Hit paper breakdown → | 2020 | 204 |
| 12 | 2018 | 188 | |
| 13 | 2017 | 176 | |
| 14 | 2015 | 174 | |
| 15 | 1997 | 172 | |
| 16 | 2013 | 167 | |
| 17 | 2003 | 163 | |
| 18 | 2003 | 159 | |
| 19 | 2008 | 158 | |
| 20 | 2006 | 156 |
About Lawrence F. Eichenfield
Lawrence F. Eichenfield is a scholar working on Dermatology, Immunology and Allergy, Physiology, Rheumatology and Immunology, having authored 462 papers that have together received 13.3k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (263 papers), Allergic Rhinitis and Sensitization (86 papers), Food Allergy and Anaphylaxis Research (80 papers), Acne and Rosacea Treatments and Effects (75 papers), Asthma and respiratory diseases (43 papers), Urticaria and Related Conditions (34 papers), Contact Dermatitis and Allergies (25 papers) and Psoriasis: Treatment and Pathogenesis (22 papers). The work is most often cited by research in Dermatology (9.0k citations), Immunology and Allergy (3.6k citations), Rheumatology (1.1k citations), Immunology (1.4k citations) and Speech and Hearing (342 citations). Lawrence F. Eichenfield has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Amy S. Paller, Sheila Fallon Friedlander, Eric L. Simpson, Jon M. Hanifin, Mark Boguniewicz, Magdalene Dohil, Andrew C. Krakowski, Adelaide A. Hebert, Bari B. Cunningham and Jonathan I. Silverberg. Their work appears in journals such as Journal of the American Academy of Dermatology, Pediatric Dermatology, Seminars in Cutaneous Medicine and Surgery, British Journal of Dermatology and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.